Gore Joins Americas Hernia Society Quality Collaborative (AHSQC) as Silver Sponsor

Partnership latest step in Gore’s ongoing commitment to improve quality of care for hernia patients

Apr 04, 2017

Gore Marks Two-Year Primary Endpoint Follow-up Milestone in Study of GORE® CARDIOFORM Septal Occluder for Patent Foramen Ovale (PFO) Closure

Completion of follow -up paves way for REDUCE Clinical Study data submission to FDA for PFO indication

Mar 30, 2017

Gore Unveils Next Evolution for TIPS Procedures: Lasting Diameter Control

GORE® VIATORR® TIPS Endoprosthesis with Controlled Expansion builds on a legacy of proven patency

Mar 09, 2017

GORE® TIGRIS® Vascular Stent Gains Health Canada Approval for Treatment of Peripheral Artery Disease

Novel device combines proven technology with modern adaptations to provide support in even the most challenging anatomies

Mar 06, 2017

FDA Approves First Balloon Expandable Stent Graft for Use in the Iliac Artery

GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis Provides Improved Outcomes in Real-World Peripheral Arterial Disease Cases

Jan 30, 2017

W. L. Gore & Associates Receives Innovative Technology Designation from Vizient, Inc. for GORE® SYNECOR Biomaterial

Designation recognizes products that bring improvements to the healthcare industry

Dec 15, 2016

Gore Joins Vascular and Endovascular Leaders in Recognizing the 2016 Pioneers in Performance for North America

Leading Practitioners and Researchers from North America Commended for Commitment to Advancing Vascular and Endovascular Therapy

Nov 16, 2016

Gore Global Registry for Endovascular Aortic Treatment Completes Enrollment

Over 5,000 patients from 114 worldwide sites provide a unique perspective of real-world conditions

Nov 15, 2016

New Technology Add-On Payment Awarded for GORE® EXCLUDER® Iliac Branch Endoprosthesis

Recognition of new technology status will provide additional hospital reimbursement for IBE when used in FDA approved indications

Sep 27, 2016